nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoflurane—ALB—atherosclerosis	0.362	1	CbGaD
Isoflurane—ALB—Rosuvastatin—atherosclerosis	0.0234	0.513	CbGbCtD
Isoflurane—CYP2B6—Simvastatin—atherosclerosis	0.0222	0.487	CbGbCtD
Isoflurane—Hepatic necrosis—Lovastatin—atherosclerosis	0.00974	0.0495	CcSEcCtD
Isoflurane—Hepatic necrosis—Simvastatin—atherosclerosis	0.00911	0.0463	CcSEcCtD
Isoflurane—Hepatic necrosis—Pravastatin—atherosclerosis	0.00824	0.0419	CcSEcCtD
Isoflurane—Laryngospasm—Niacin—atherosclerosis	0.00651	0.0331	CcSEcCtD
Isoflurane—Necrosis—Niacin—atherosclerosis	0.00619	0.0315	CcSEcCtD
Isoflurane—Hepatocellular injury—Ezetimibe—atherosclerosis	0.00555	0.0282	CcSEcCtD
Isoflurane—Hepatic failure—Rosuvastatin—atherosclerosis	0.00539	0.0274	CcSEcCtD
Isoflurane—Hepatocellular injury—Simvastatin—atherosclerosis	0.00529	0.0269	CcSEcCtD
Isoflurane—Hepatocellular injury—Pravastatin—atherosclerosis	0.00479	0.0243	CcSEcCtD
Isoflurane—Hepatic function abnormal—Lovastatin—atherosclerosis	0.0047	0.0239	CcSEcCtD
Isoflurane—Hepatic failure—Lovastatin—atherosclerosis	0.00457	0.0232	CcSEcCtD
Isoflurane—Hepatic failure—Ezetimibe—atherosclerosis	0.00448	0.0228	CcSEcCtD
Isoflurane—Hepatic function abnormal—Simvastatin—atherosclerosis	0.0044	0.0224	CcSEcCtD
Isoflurane—Hepatic failure—Simvastatin—atherosclerosis	0.00428	0.0217	CcSEcCtD
Isoflurane—Hepatic function abnormal—Niacin—atherosclerosis	0.00404	0.0205	CcSEcCtD
Isoflurane—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00398	0.0202	CcSEcCtD
Isoflurane—Hepatic failure—Pravastatin—atherosclerosis	0.00387	0.0197	CcSEcCtD
Isoflurane—Jaundice—Rosuvastatin—atherosclerosis	0.00364	0.0185	CcSEcCtD
Isoflurane—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00353	0.018	CcSEcCtD
Isoflurane—Hepatitis—Rosuvastatin—atherosclerosis	0.00335	0.017	CcSEcCtD
Isoflurane—Jaundice—Ezetimibe—atherosclerosis	0.00303	0.0154	CcSEcCtD
Isoflurane—Arrhythmia—Rosuvastatin—atherosclerosis	0.003	0.0152	CcSEcCtD
Isoflurane—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00294	0.0149	CcSEcCtD
Isoflurane—Jaundice—Simvastatin—atherosclerosis	0.00289	0.0147	CcSEcCtD
Isoflurane—Hepatitis—Lovastatin—atherosclerosis	0.00284	0.0144	CcSEcCtD
Isoflurane—Hepatitis—Ezetimibe—atherosclerosis	0.00279	0.0142	CcSEcCtD
Isoflurane—Hepatitis—Simvastatin—atherosclerosis	0.00266	0.0135	CcSEcCtD
Isoflurane—Jaundice—Niacin—atherosclerosis	0.00265	0.0135	CcSEcCtD
Isoflurane—Jaundice—Pravastatin—atherosclerosis	0.00261	0.0133	CcSEcCtD
Isoflurane—Chills—Lovastatin—atherosclerosis	0.00255	0.013	CcSEcCtD
Isoflurane—Cough—Rosuvastatin—atherosclerosis	0.00255	0.013	CcSEcCtD
Isoflurane—KCNK3—cardiovascular system—atherosclerosis	0.00248	0.053	CbGeAlD
Isoflurane—Hepatitis—Niacin—atherosclerosis	0.00244	0.0124	CcSEcCtD
Isoflurane—Hepatitis—Pravastatin—atherosclerosis	0.0024	0.0122	CcSEcCtD
Isoflurane—Chills—Simvastatin—atherosclerosis	0.00239	0.0121	CcSEcCtD
Isoflurane—CALM2—artery—atherosclerosis	0.00228	0.0487	CbGeAlD
Isoflurane—CALM1—artery—atherosclerosis	0.00227	0.0484	CbGeAlD
Isoflurane—KCNK2—adipose tissue—atherosclerosis	0.00226	0.0484	CbGeAlD
Isoflurane—Cardiac disorder—Pravastatin—atherosclerosis	0.00223	0.0113	CcSEcCtD
Isoflurane—Chills—Niacin—atherosclerosis	0.00219	0.0111	CcSEcCtD
Isoflurane—Arrhythmia—Niacin—atherosclerosis	0.00218	0.0111	CcSEcCtD
Isoflurane—Chills—Pravastatin—atherosclerosis	0.00216	0.011	CcSEcCtD
Isoflurane—GLRB—cardiovascular system—atherosclerosis	0.00215	0.046	CbGeAlD
Isoflurane—Arrhythmia—Pravastatin—atherosclerosis	0.00215	0.0109	CcSEcCtD
Isoflurane—Cough—Ezetimibe—atherosclerosis	0.00212	0.0108	CcSEcCtD
Isoflurane—Enflurane—ALB—atherosclerosis	0.00207	0.393	CrCbGaD
Isoflurane—CALM2—endothelium—atherosclerosis	0.00192	0.0411	CbGeAlD
Isoflurane—CALM1—endothelium—atherosclerosis	0.00191	0.0409	CbGeAlD
Isoflurane—GLRB—adipose tissue—atherosclerosis	0.0019	0.0405	CbGeAlD
Isoflurane—Cough—Niacin—atherosclerosis	0.00185	0.00943	CcSEcCtD
Isoflurane—Cough—Pravastatin—atherosclerosis	0.00183	0.00928	CcSEcCtD
Isoflurane—CALM2—blood vessel—atherosclerosis	0.00177	0.0379	CbGeAlD
Isoflurane—CALM1—blood vessel—atherosclerosis	0.00176	0.0377	CbGeAlD
Isoflurane—GRIA1—adipose tissue—atherosclerosis	0.00176	0.0377	CbGeAlD
Isoflurane—ND1—cardiovascular system—atherosclerosis	0.00172	0.0367	CbGeAlD
Isoflurane—Halothane—ALB—atherosclerosis	0.00169	0.321	CrCbGaD
Isoflurane—Hypotension—Niacin—atherosclerosis	0.00162	0.00824	CcSEcCtD
Isoflurane—Body temperature increased—Lovastatin—atherosclerosis	0.0016	0.00811	CcSEcCtD
Isoflurane—ATP5D—connective tissue—atherosclerosis	0.00159	0.034	CbGeAlD
Isoflurane—Body temperature increased—Ezetimibe—atherosclerosis	0.00157	0.00796	CcSEcCtD
Isoflurane—Rash—Rosuvastatin—atherosclerosis	0.0015	0.00764	CcSEcCtD
Isoflurane—Dermatitis—Rosuvastatin—atherosclerosis	0.0015	0.00763	CcSEcCtD
Isoflurane—Desflurane—ALB—atherosclerosis	0.0015	0.285	CrCbGaD
Isoflurane—Body temperature increased—Simvastatin—atherosclerosis	0.00149	0.00759	CcSEcCtD
Isoflurane—Nausea—Rosuvastatin—atherosclerosis	0.00142	0.00719	CcSEcCtD
Isoflurane—ATP5D—cardiovascular system—atherosclerosis	0.00139	0.0296	CbGeAlD
Isoflurane—Body temperature increased—Niacin—atherosclerosis	0.00137	0.00697	CcSEcCtD
Isoflurane—ATP2C1—cardiovascular system—atherosclerosis	0.00137	0.0292	CbGeAlD
Isoflurane—Body temperature increased—Pravastatin—atherosclerosis	0.00135	0.00686	CcSEcCtD
Isoflurane—Vomiting—Lovastatin—atherosclerosis	0.00128	0.00653	CcSEcCtD
Isoflurane—Rash—Lovastatin—atherosclerosis	0.00127	0.00647	CcSEcCtD
Isoflurane—Dermatitis—Lovastatin—atherosclerosis	0.00127	0.00647	CcSEcCtD
Isoflurane—Vomiting—Ezetimibe—atherosclerosis	0.00126	0.0064	CcSEcCtD
Isoflurane—Rash—Ezetimibe—atherosclerosis	0.00125	0.00635	CcSEcCtD
Isoflurane—Dermatitis—Ezetimibe—atherosclerosis	0.00125	0.00634	CcSEcCtD
Isoflurane—ATP5D—adipose tissue—atherosclerosis	0.00122	0.0261	CbGeAlD
Isoflurane—ATP2C1—adipose tissue—atherosclerosis	0.00121	0.0258	CbGeAlD
Isoflurane—Vomiting—Simvastatin—atherosclerosis	0.0012	0.0061	CcSEcCtD
Isoflurane—Nausea—Lovastatin—atherosclerosis	0.0012	0.0061	CcSEcCtD
Isoflurane—Rash—Simvastatin—atherosclerosis	0.00119	0.00605	CcSEcCtD
Isoflurane—Dermatitis—Simvastatin—atherosclerosis	0.00119	0.00605	CcSEcCtD
Isoflurane—Nausea—Ezetimibe—atherosclerosis	0.00118	0.00598	CcSEcCtD
Isoflurane—Nausea—Simvastatin—atherosclerosis	0.00112	0.0057	CcSEcCtD
Isoflurane—Vomiting—Niacin—atherosclerosis	0.0011	0.00561	CcSEcCtD
Isoflurane—Rash—Niacin—atherosclerosis	0.00109	0.00556	CcSEcCtD
Isoflurane—Dermatitis—Niacin—atherosclerosis	0.00109	0.00555	CcSEcCtD
Isoflurane—Vomiting—Pravastatin—atherosclerosis	0.00109	0.00552	CcSEcCtD
Isoflurane—Rash—Pravastatin—atherosclerosis	0.00108	0.00547	CcSEcCtD
Isoflurane—Dermatitis—Pravastatin—atherosclerosis	0.00108	0.00547	CcSEcCtD
Isoflurane—ND1—liver—atherosclerosis	0.00106	0.0227	CbGeAlD
Isoflurane—Nausea—Niacin—atherosclerosis	0.00103	0.00524	CcSEcCtD
Isoflurane—Nausea—Pravastatin—atherosclerosis	0.00101	0.00516	CcSEcCtD
Isoflurane—GABRB3—connective tissue—atherosclerosis	0.000997	0.0213	CbGeAlD
Isoflurane—GABRA2—adipose tissue—atherosclerosis	0.00091	0.0195	CbGeAlD
Isoflurane—CALM2—connective tissue—atherosclerosis	0.000909	0.0194	CbGeAlD
Isoflurane—CALM1—connective tissue—atherosclerosis	0.000905	0.0193	CbGeAlD
Isoflurane—GABRE—adipose tissue—atherosclerosis	0.000902	0.0193	CbGeAlD
Isoflurane—CALM3—adipose tissue—atherosclerosis	0.000888	0.019	CbGeAlD
Isoflurane—ATP5D—liver—atherosclerosis	0.000857	0.0183	CbGeAlD
Isoflurane—ATP2C1—liver—atherosclerosis	0.000846	0.0181	CbGeAlD
Isoflurane—CALM2—cardiovascular system—atherosclerosis	0.000791	0.0169	CbGeAlD
Isoflurane—CALM1—cardiovascular system—atherosclerosis	0.000787	0.0168	CbGeAlD
Isoflurane—CALM2—adipose tissue—atherosclerosis	0.000697	0.0149	CbGeAlD
Isoflurane—CALM1—adipose tissue—atherosclerosis	0.000694	0.0148	CbGeAlD
Isoflurane—CALM3—liver—atherosclerosis	0.000623	0.0133	CbGeAlD
Isoflurane—CYP2B6—cardiovascular system—atherosclerosis	0.000588	0.0126	CbGeAlD
Isoflurane—ALB—liver—atherosclerosis	0.000577	0.0123	CbGeAlD
Isoflurane—CYP2E1—cardiovascular system—atherosclerosis	0.000552	0.0118	CbGeAlD
Isoflurane—GABRB3—liver—atherosclerosis	0.000536	0.0115	CbGeAlD
Isoflurane—CALM2—liver—atherosclerosis	0.000489	0.0105	CbGeAlD
Isoflurane—CALM1—liver—atherosclerosis	0.000487	0.0104	CbGeAlD
Isoflurane—CYP2B6—liver—atherosclerosis	0.000364	0.00777	CbGeAlD
Isoflurane—CYP2E1—liver—atherosclerosis	0.000341	0.0073	CbGeAlD
Isoflurane—CALM3—Signaling Pathways—IGF2—atherosclerosis	1.42e-05	4.13e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—MTHFR—atherosclerosis	1.42e-05	4.13e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—PPARA—atherosclerosis	1.4e-05	4.07e-05	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—TGFB1—atherosclerosis	1.39e-05	4.06e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—PPARA—atherosclerosis	1.39e-05	4.05e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—GSTM1—atherosclerosis	1.39e-05	4.04e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—AGT—atherosclerosis	1.38e-05	4.03e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—MMP3—atherosclerosis	1.38e-05	4.02e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—MMP3—atherosclerosis	1.38e-05	4.02e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—APOB—atherosclerosis	1.38e-05	4.01e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—IGF2—atherosclerosis	1.37e-05	4e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—IGF2—atherosclerosis	1.37e-05	4e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—MTHFR—atherosclerosis	1.37e-05	3.99e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—MTHFR—atherosclerosis	1.37e-05	3.99e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—LPL—atherosclerosis	1.36e-05	3.96e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—EDN1—atherosclerosis	1.36e-05	3.95e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—APOE—atherosclerosis	1.36e-05	3.95e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—AGT—atherosclerosis	1.36e-05	3.94e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—AGT—atherosclerosis	1.35e-05	3.92e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CCL5—atherosclerosis	1.35e-05	3.92e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—INS—atherosclerosis	1.35e-05	3.92e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—PPARA—atherosclerosis	1.35e-05	3.91e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—PPARA—atherosclerosis	1.35e-05	3.91e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—CAV1—atherosclerosis	1.34e-05	3.91e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—APOA1—atherosclerosis	1.34e-05	3.9e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—APOB—atherosclerosis	1.33e-05	3.88e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—APOB—atherosclerosis	1.33e-05	3.88e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—GPX1—atherosclerosis	1.33e-05	3.87e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—APOE—atherosclerosis	1.33e-05	3.86e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—APOE—atherosclerosis	1.32e-05	3.84e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—LPL—atherosclerosis	1.32e-05	3.83e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—CAV1—atherosclerosis	1.32e-05	3.83e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—APOA1—atherosclerosis	1.31e-05	3.82e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—EDN1—atherosclerosis	1.31e-05	3.82e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—EDN1—atherosclerosis	1.31e-05	3.82e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—CAV1—atherosclerosis	1.31e-05	3.8e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—APOA1—atherosclerosis	1.3e-05	3.8e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—AGT—atherosclerosis	1.3e-05	3.79e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—AGT—atherosclerosis	1.3e-05	3.79e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CCL5—atherosclerosis	1.3e-05	3.79e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CCL5—atherosclerosis	1.3e-05	3.79e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—INS—atherosclerosis	1.3e-05	3.79e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—INS—atherosclerosis	1.3e-05	3.79e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—CD36—atherosclerosis	1.29e-05	3.77e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—PRKCG—atherosclerosis	1.28e-05	3.72e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—APOE—atherosclerosis	1.28e-05	3.71e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—APOE—atherosclerosis	1.28e-05	3.71e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—LPL—atherosclerosis	1.27e-05	3.71e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—LPL—atherosclerosis	1.27e-05	3.71e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—CAV1—atherosclerosis	1.26e-05	3.68e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—CAV1—atherosclerosis	1.26e-05	3.68e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—APOA1—atherosclerosis	1.26e-05	3.67e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—APOA1—atherosclerosis	1.26e-05	3.67e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—SPP1—atherosclerosis	1.25e-05	3.63e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—CXCL8—atherosclerosis	1.24e-05	3.61e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—PRKCG—atherosclerosis	1.24e-05	3.6e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—PRKCG—atherosclerosis	1.24e-05	3.6e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—SERPINE1—atherosclerosis	1.24e-05	3.6e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—MTHFR—atherosclerosis	1.23e-05	3.57e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—PIK3CG—atherosclerosis	1.22e-05	3.56e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—IFNG—atherosclerosis	1.22e-05	3.55e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—SPP1—atherosclerosis	1.21e-05	3.51e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—SPP1—atherosclerosis	1.21e-05	3.51e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—PPARA—atherosclerosis	1.2e-05	3.5e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—CXCL8—atherosclerosis	1.2e-05	3.49e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—CXCL8—atherosclerosis	1.2e-05	3.49e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—PIK3CG—atherosclerosis	1.2e-05	3.49e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—SERPINE1—atherosclerosis	1.2e-05	3.48e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—SERPINE1—atherosclerosis	1.2e-05	3.48e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—PIK3CG—atherosclerosis	1.19e-05	3.47e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—PPARG—atherosclerosis	1.18e-05	3.44e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—NOS3—atherosclerosis	1.18e-05	3.44e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—IFNG—atherosclerosis	1.18e-05	3.43e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—IFNG—atherosclerosis	1.18e-05	3.43e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—AGT—atherosclerosis	1.17e-05	3.39e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—INS—atherosclerosis	1.16e-05	3.37e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—PPARG—atherosclerosis	1.16e-05	3.37e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—PDGFB—atherosclerosis	1.15e-05	3.36e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—PIK3CG—atherosclerosis	1.15e-05	3.35e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—PIK3CG—atherosclerosis	1.15e-05	3.35e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—PPARG—atherosclerosis	1.15e-05	3.35e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—NOS3—atherosclerosis	1.14e-05	3.32e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—NOS3—atherosclerosis	1.14e-05	3.32e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—APOE—atherosclerosis	1.14e-05	3.32e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—INS—atherosclerosis	1.13e-05	3.3e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—CAV1—atherosclerosis	1.13e-05	3.29e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—APOA1—atherosclerosis	1.13e-05	3.28e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—INS—atherosclerosis	1.13e-05	3.28e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—AGT—atherosclerosis	1.13e-05	3.28e-05	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—AKT1—atherosclerosis	1.12e-05	3.26e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—PDGFB—atherosclerosis	1.12e-05	3.25e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—PDGFB—atherosclerosis	1.12e-05	3.25e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—PPARG—atherosclerosis	1.11e-05	3.24e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—PPARG—atherosclerosis	1.11e-05	3.24e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—LEP—atherosclerosis	1.1e-05	3.21e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—APOE—atherosclerosis	1.1e-05	3.21e-05	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—IL6—atherosclerosis	1.09e-05	3.18e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CAV1—atherosclerosis	1.09e-05	3.18e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—APOA1—atherosclerosis	1.09e-05	3.17e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—INS—atherosclerosis	1.09e-05	3.17e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—INS—atherosclerosis	1.09e-05	3.17e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—AGT—atherosclerosis	1.09e-05	3.17e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—AGT—atherosclerosis	1.09e-05	3.17e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—IL1B—atherosclerosis	1.09e-05	3.17e-05	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—AKT1—atherosclerosis	1.08e-05	3.16e-05	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—AKT1—atherosclerosis	1.08e-05	3.16e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—PTGS2—atherosclerosis	1.08e-05	3.14e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—APOE—atherosclerosis	1.07e-05	3.11e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—LEP—atherosclerosis	1.07e-05	3.11e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—LEP—atherosclerosis	1.07e-05	3.11e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—APOE—atherosclerosis	1.07e-05	3.11e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—ALB—atherosclerosis	1.06e-05	3.09e-05	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—IL6—atherosclerosis	1.06e-05	3.08e-05	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—IL6—atherosclerosis	1.06e-05	3.08e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CAV1—atherosclerosis	1.06e-05	3.08e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CAV1—atherosclerosis	1.06e-05	3.08e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—APOA1—atherosclerosis	1.06e-05	3.07e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—APOA1—atherosclerosis	1.06e-05	3.07e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—ESR1—atherosclerosis	1.05e-05	3.07e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—IL1B—atherosclerosis	1.05e-05	3.06e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—IL1B—atherosclerosis	1.05e-05	3.06e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—PTGS2—atherosclerosis	1.04e-05	3.04e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—PTGS2—atherosclerosis	1.04e-05	3.04e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—F2—atherosclerosis	1.04e-05	3.03e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—ALB—atherosclerosis	1.04e-05	3.03e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—ALB—atherosclerosis	1.03e-05	3.01e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—PIK3CG—atherosclerosis	1.03e-05	3e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—ESR1—atherosclerosis	1.02e-05	2.97e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—ESR1—atherosclerosis	1.02e-05	2.97e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—NOS3—atherosclerosis	1.02e-05	2.96e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—NFKB1—atherosclerosis	1.02e-05	2.95e-05	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—AKT1—atherosclerosis	1.01e-05	2.94e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—F2—atherosclerosis	1.01e-05	2.93e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—F2—atherosclerosis	1.01e-05	2.93e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—ALB—atherosclerosis	1e-05	2.91e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—ALB—atherosclerosis	1e-05	2.91e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—MAPK8—atherosclerosis	9.98e-06	2.9e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—PIK3CG—atherosclerosis	9.96e-06	2.9e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—NOS3—atherosclerosis	9.95e-06	2.9e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—PPARG—atherosclerosis	9.94e-06	2.89e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—NOS3—atherosclerosis	9.89e-06	2.88e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—NFKB1—atherosclerosis	9.82e-06	2.86e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—NFKB1—atherosclerosis	9.82e-06	2.86e-05	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—AKT1—atherosclerosis	9.76e-06	2.84e-05	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—AKT1—atherosclerosis	9.76e-06	2.84e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—INS—atherosclerosis	9.75e-06	2.84e-05	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—AKT1—atherosclerosis	9.7e-06	2.82e-05	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—AKT1—atherosclerosis	9.69e-06	2.82e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—MAPK8—atherosclerosis	9.65e-06	2.81e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—MAPK8—atherosclerosis	9.65e-06	2.81e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—PIK3CG—atherosclerosis	9.63e-06	2.8e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—PIK3CG—atherosclerosis	9.63e-06	2.8e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—NOS3—atherosclerosis	9.57e-06	2.78e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—NOS3—atherosclerosis	9.57e-06	2.78e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—MAPK3—atherosclerosis	9.54e-06	2.78e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—INS—atherosclerosis	9.43e-06	2.74e-05	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—AKT1—atherosclerosis	9.38e-06	2.73e-05	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—AKT1—atherosclerosis	9.38e-06	2.73e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—PTGS2—atherosclerosis	9.29e-06	2.7e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CCL2—atherosclerosis	9.28e-06	2.7e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—MAPK3—atherosclerosis	9.23e-06	2.68e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—MAPK3—atherosclerosis	9.23e-06	2.68e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—STAT3—atherosclerosis	9.12e-06	2.65e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—INS—atherosclerosis	9.12e-06	2.65e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—INS—atherosclerosis	9.12e-06	2.65e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—IGF1—atherosclerosis	9.12e-06	2.65e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—PTGS2—atherosclerosis	9.1e-06	2.65e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—PTGS2—atherosclerosis	9.04e-06	2.63e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CCL2—atherosclerosis	8.97e-06	2.61e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CCL2—atherosclerosis	8.97e-06	2.61e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—STAT3—atherosclerosis	8.82e-06	2.57e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—STAT3—atherosclerosis	8.82e-06	2.57e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—IGF1—atherosclerosis	8.82e-06	2.57e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—IGF1—atherosclerosis	8.82e-06	2.57e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—PTGS2—atherosclerosis	8.75e-06	2.55e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—PTGS2—atherosclerosis	8.75e-06	2.55e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—MAPK3—atherosclerosis	8.72e-06	2.54e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—SERPINE1—atherosclerosis	8.66e-06	2.52e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—NOS3—atherosclerosis	8.55e-06	2.49e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—MAPK3—atherosclerosis	8.43e-06	2.45e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—MAPK3—atherosclerosis	8.43e-06	2.45e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—STAT3—atherosclerosis	8.42e-06	2.45e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—SERPINE1—atherosclerosis	8.38e-06	2.44e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—SERPINE1—atherosclerosis	8.38e-06	2.44e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—NOS3—atherosclerosis	8.27e-06	2.41e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—STAT3—atherosclerosis	8.15e-06	2.37e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—STAT3—atherosclerosis	8.15e-06	2.37e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—MAPK3—atherosclerosis	8.05e-06	2.34e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—NOS3—atherosclerosis	8e-06	2.33e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—NOS3—atherosclerosis	8e-06	2.33e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—PTGS2—atherosclerosis	7.82e-06	2.28e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—TGFB1—atherosclerosis	7.81e-06	2.27e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—MAPK3—atherosclerosis	7.78e-06	2.26e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—MAPK3—atherosclerosis	7.78e-06	2.26e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—TGFB1—atherosclerosis	7.55e-06	2.2e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—TGFB1—atherosclerosis	7.55e-06	2.2e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CXCL8—atherosclerosis	7.33e-06	2.13e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CXCL8—atherosclerosis	7.09e-06	2.06e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CXCL8—atherosclerosis	7.09e-06	2.06e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—IL6—atherosclerosis	6.97e-06	2.03e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—IL6—atherosclerosis	6.75e-06	1.96e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—IL6—atherosclerosis	6.75e-06	1.96e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—MMP9—atherosclerosis	6.63e-06	1.93e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—NFKB1—atherosclerosis	6.56e-06	1.91e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—MAPK8—atherosclerosis	6.45e-06	1.88e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—AKT1—atherosclerosis	6.43e-06	1.87e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—MMP9—atherosclerosis	6.42e-06	1.87e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—MMP9—atherosclerosis	6.42e-06	1.87e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—IL6—atherosclerosis	6.37e-06	1.85e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—NFKB1—atherosclerosis	6.35e-06	1.85e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—NFKB1—atherosclerosis	6.35e-06	1.85e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—MAPK8—atherosclerosis	6.24e-06	1.82e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—MAPK8—atherosclerosis	6.24e-06	1.82e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—AKT1—atherosclerosis	6.22e-06	1.81e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—AKT1—atherosclerosis	6.22e-06	1.81e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—IL6—atherosclerosis	6.16e-06	1.79e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—IL6—atherosclerosis	6.16e-06	1.79e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—VEGFA—atherosclerosis	5.96e-06	1.73e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—STAT3—atherosclerosis	5.9e-06	1.72e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—IL6—atherosclerosis	5.88e-06	1.71e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—AKT1—atherosclerosis	5.88e-06	1.71e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—VEGFA—atherosclerosis	5.76e-06	1.68e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—VEGFA—atherosclerosis	5.76e-06	1.68e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—STAT3—atherosclerosis	5.71e-06	1.66e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—STAT3—atherosclerosis	5.71e-06	1.66e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—IL6—atherosclerosis	5.69e-06	1.66e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—IL6—atherosclerosis	5.69e-06	1.66e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—AKT1—atherosclerosis	5.69e-06	1.65e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—AKT1—atherosclerosis	5.69e-06	1.65e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—MAPK3—atherosclerosis	5.63e-06	1.64e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—TGFB1—atherosclerosis	5.47e-06	1.59e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—MAPK3—atherosclerosis	5.45e-06	1.59e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—MAPK3—atherosclerosis	5.45e-06	1.59e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—AKT1—atherosclerosis	5.43e-06	1.58e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—TGFB1—atherosclerosis	5.29e-06	1.54e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—TGFB1—atherosclerosis	5.29e-06	1.54e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—AKT1—atherosclerosis	5.25e-06	1.53e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—AKT1—atherosclerosis	5.25e-06	1.53e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—AKT1—atherosclerosis	4.67e-06	1.36e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—AKT1—atherosclerosis	4.57e-06	1.33e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—AKT1—atherosclerosis	4.55e-06	1.32e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—AKT1—atherosclerosis	4.4e-06	1.28e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—AKT1—atherosclerosis	4.4e-06	1.28e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—IL6—atherosclerosis	4.12e-06	1.2e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—IL6—atherosclerosis	3.99e-06	1.16e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—IL6—atherosclerosis	3.99e-06	1.16e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—AKT1—atherosclerosis	3.93e-06	1.14e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—AKT1—atherosclerosis	3.8e-06	1.11e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—AKT1—atherosclerosis	3.68e-06	1.07e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—AKT1—atherosclerosis	3.68e-06	1.07e-05	CbGpPWpGaD
